Targeting Cell 'Powerhouses' To Overcome Resistance To Anti-Cancer Drugs
5/26/2013
Re-routing anti-cancer drugs to the "power plants" that make energy to keep cells alive is a promising but long-neglected approach to preventing emergence of the drug-resistant forms of cancer - source of a serious medical problem, scientists are reporting. That's the conclusion of a new study published in the journal ACS Chemical Biology...
Algorithm Developed Offering New Guidelines On Blood-Ordering For Surgical Patients
5/26/2013
Johns Hopkins researchers have developed new guidelines - the first in more than 35 years - to govern the amount of blood ordered for surgical patients. The recommendations, based on a lengthy study of blood use at The Johns Hopkins Hospital (JHH), can potentially save the medical center more than $200,000 a year and improve patient safety, researchers say...
Anti-Cancer Drug Reverses Alzheimer's Disease In Mice
5/25/2013
An anti-cancer drug may reverse memory problems in an Alzheimer's Disease mouse model, according to new research carried out at the University of Pittsburgh Graduate School of Public Health. The study, published in the journal Science, examined previously published outcomes on the drug bexarotene - which is approved by the U.S...
Netherlands first to approve new fixed-dose combination treatment for men with lower urinary tract symptoms associated with BPH ASTELLAS PHARMA EUROPE B.V., the European subsidiary of Tokyo-based Astellas Pharma Inc.(Tokyo:4503), have announced the Dutch Medicines Evaluation Board (MEB) has granted marketing authorisation for VESOMNI in the Netherlands...
Anti-Cancer Drug Reverses Alzheimer's Disease In Mice
5/25/2013
An anti-cancer drug may reverse memory problems in an Alzheimer's Disease mouse model, according to new research carried out at the University of Pittsburgh Graduate School of Public Health. The study, published in the journal Science, examined previously published outcomes on the drug bexarotene - which is approved by the U.S...
Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added heart toxicity, according to the results of a study published online today in Blood, the Journal of the American Society of Hematology (ASH)...
Scientists Make Breast Cancer Advance That Turns Previous Thinking On Its Head
5/24/2013
Scientists at the University of East Anglia (UEA) have made an advance in breast cancer research which shows how some enzymes released by cancerous cells could have a protective function...
Early screening for prostate cancer could become as easy for men as personal pregnancy testing is for women, thanks to UC Irvine research published in the /iJournal of the American Chemical Society...
New Mouse Model Helping To Keep Stem Cells Strong
5/24/2013
When infections occur in the body, stem cells in the blood often jump into action by multiplying and differentiating into mature immune cells that can fight off illness. But repeated infections and inflammation can deplete these cell populations, potentially leading to the development of serious blood conditions such as cancer...
Radioactive Nanoparticles Developed That Target Cancer Cells
5/24/2013
Cancers of all types become most deadly when they metastasize and spread tumors throughout the body. Once cancer has reached this stage, it becomes very difficult for doctors to locate and treat the numerous tumors that can develop. Now, researchers at the University of Missouri have found a way to create radioactive nanoparticles that target lymphoma tumor cells wherever they may be in the body...